Not all tumor cell lines are suitable for in vivo drug efficacy study due to either inconsistent tumor take rate or unacceptable large tumor size variation within the same treatment group. Even for tumor cell lines that are well published in the literature, protocols need to be validated for each lab since certain changes in the environment and mouse genetic background may occur, which can change the growth behavior of these models.

In order to provide the highest quality service, we have established a set of stringent criteria to validate our in vivo tumor models. We guarantee the successful establishment of our validated models, and will repeat any study without charge if any of our validated tumor lines failed to establish in nude mice.

List of validated xenograft tumor models: